Medical Technologies announced today that its sensory insoles, analytics platform, and remote monitoring program will be used in a new clinical trial funded by the National Institutes of Health (NIH).

Dr. Khaled Khalaf with Vital Heart & Vein explains how the FDA-approved Rybelsus may help high-risk adults with Type 2 ...

With its new investment, Beacon plans to scale its technology and operations. It aims to accelerate neurobiomarker discovery ...

The disposable single-use devices, which is as discreet as adhesive bandages, is activated simply by placement on the body. The device senses the body and, over a few minutes or an hour, delivers a ...

Diabetes is one of the most common chronic health conditions worldwide.1 Daily management is tough, but one of the biggest ...

Autoimmune diseases can affect just about every part of the body – and tens of millions of people. While most common in women ...

Since her 2021 diabetes diagnosis, Stephanie Guignard, a nurse practitioner, has made it her mission to educate people on how ...

(Family Features) Heart health is about more than just the heart itself. It’s a two-way street between the heart and the rest of the body. However, many U.S. adults aren’t aware of the connection ...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of Texas Tech Health El ...

Poor blood sugar control in adolescence increases the risk of painful future complications for people with type 1 diabetes, research co-led by University of Michigan suggests. The study, which ...